New inhaler could ease IUD insertion pain
NCT ID NCT07295054
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether inhaling a drug called methoxyflurane (Penthrox) can reduce pain and anxiety during IUD insertion. About 110 people will receive either the drug or a placebo inhaler. The goal is to see if this quick, self-administered pain relief improves patient satisfaction compared to standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Methoxyflurane (Penthrox) inhaled via a handheld inhaler
- What this could lead to
- If it works, this could offer a fast, self-administered pain relief option for IUD insertion, making the procedure more comfortable.
- What could go wrong
- This is a small, early-phase trial (110 participants) comparing methoxyflurane to a placebo inhaler. It may not show a meaningful benefit, and side effects like dizziness or nausea are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IUD are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Women's College Hospital
RECRUITINGToronto, Ontario, M5S 1B2, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.